已收盘 01-30 16:00:00 美东时间
+0.500
+9.80%
Altimmune shares are tumbling on Wednesday following the company's announcement of a $75 million registered direct offering of common stock.
01-29 05:13
Gainers ENvue Medical (NASDAQ:FEED) stock moved upwards by 19.0% to $1.25 duri...
01-28 20:05
Altimmune ($ALT) has raised $75 million in new funding, giving the biotech comp...
01-28 16:09
Altimmune (ALT) entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17.05M shares pursuant to a registered direct offering. The offe...
01-28 12:39
Altimmune Raises $75 Million in Direct Offering of Shares and Pre-Funded Warrants Altimmune Inc. has announced a registered direct offering involving the sale of 17,045,454 shares of its common stock or pre-funded warrants in lieu thereof, to a new institutional investor. The offering is expected to
01-28 10:25
Altimmune, a late clinical-stage biopharmaceutical company, has entered into a securities purchase agreement with a new institutional investor for the sale of 17,045,454 shares of common stock, expected to raise approximately $75 million. The funds will be used to prepare for its upcoming Phase 3 trial for pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) and for general corporate purposes. The offering is expected to close o...
01-28 02:25
U.S. stocks were mixed, with the Dow Jones falling around 200 points on Friday....
01-23 23:55
截止1月22日10点11分,上证指数涨0.54%,深证成指涨0.45%,创业板指涨0.58%。油气开采及服务、可燃冰、军工装备等板块涨幅居前。 ETF方面,标普...
01-22 10:59
Insiders have been trading these 5 stocks: (($ENVX)), (($SERV)), (($EOG)), (($A...
01-10 21:01
Shares of Altimmune, Inc. (NASDAQ: ALT) are rising Monday after the FDA granted Breakthrough Therapy Designation for Pemvidutide.
01-06 00:04